Stertzer S H, Rosenblum J, Shaw R E, Sugeng I, Hidalgo B, Ryan C, Hansell H N, Murphy M C, Myler R K
San Francisco Heart Institute, Seton Medical Center, Daly City, California 94015.
J Am Coll Cardiol. 1993 Feb;21(2):287-95. doi: 10.1016/0735-1097(93)90665-n.
The aim of this study was to assess the utility of percutaneous transluminal coronary rotational ablation in the treatment of coronary artery disease.
Although numerous advances have been made in the treatment of coronary artery disease, there are lesions with complex morphology that are not amenable to current intravascular therapy.
A consecutive series of 242 patients having 302 coronary rotational ablation procedures was analyzed. One hundred nineteen (49%) of the patients had previously undergone attempted coronary angioplasty, which was unsuccessful in 31 patients (13%). The left ventricular ejection fraction was normal in 196 patients (81%). The ablation procedure was attempted in 308 vessels and 346 lesions. Of the 346 lesions treated, 26 (7.5%) were classified as American College of Cardiology/American Heart Association type A, and 320 (92.5%) as either type B or type C.
Procedural success was achieved in 284 (94%) of the 302 procedures and 330 (95.4%) of the 346 lesions in which ablation was attempted. Five procedures (1.7%) were unsuccessful, but no cardiac event occurred during the hospital stay. A major cardiac event occurred in 13 cases (4.3%); 9 (3%) of these complications were due to the ablation procedure. Six patients sustained a Q wave myocardial infarction alone, two had a Q wave infarction and required emergency surgery and one needed emergency surgery but did not have a Q wave infarction. No procedural deaths were attributed to the ablation procedure. Follow-up has been obtained in 182 of the 242 patients at a mean interval of 9 +/- 5 months. Of the 182 patients, 174 (95.6%) were alive and free of myocardial infarction. Angiographic follow-up is available thus far in 87 patients. By combining angiographic and clinical outcome, an overall estimated restenosis rate of 37.4% (68 of 182) was calculated.
These data suggest that coronary rotational ablation can be performed on lesions with a variety of morphologic features with high initial success rates. The overall rate of restenosis is similar to that of balloon angioplasty.
本研究旨在评估经皮腔内冠状动脉旋磨术在冠状动脉疾病治疗中的效用。
尽管冠状动脉疾病的治疗已取得诸多进展,但仍存在形态复杂、不适于当前血管内治疗的病变。
对连续进行302例冠状动脉旋磨术的242例患者进行分析。119例(49%)患者此前曾尝试冠状动脉血管成形术,其中31例(13%)未成功。196例(81%)患者左心室射血分数正常。对308支血管和346处病变尝试进行旋磨术。在接受治疗的346处病变中,26处(7.5%)被归类为美国心脏病学会/美国心脏协会A型,320处(92.5%)为B型或C型。
302例手术中有284例(94%)、尝试旋磨术的346处病变中有330处(95.4%)手术成功。5例手术(1.7%)未成功,但住院期间未发生心脏事件。13例(4.3%)发生重大心脏事件;其中9例(3%)并发症归因于旋磨术。6例患者单独发生Q波心肌梗死,2例发生Q波梗死并需要急诊手术,1例需要急诊手术但未发生Q波梗死。无手术死亡归因于旋磨术。242例患者中有182例获得随访,平均随访间隔为9±5个月。在这182例患者中,174例(95.6%)存活且无心肌梗死。迄今为止,87例患者有血管造影随访结果。综合血管造影和临床结果,计算出总体估计再狭窄率为37.4%(182例中的68例)。
这些数据表明,冠状动脉旋磨术可用于多种形态特征的病变,初始成功率较高。总体再狭窄率与球囊血管成形术相似。